Pharmaion
+1 8448850006     sales@pharmaion.com
Report Description

Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020

Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020
  • Publish Date:January, 2016
  • Format : PDF
  • Pages : 122

In Europe, lung cancer accounts for around 20% of the total deaths due to cancer. With a 5-year survival rate of 11.2% for men and 13.9% for women in 2014, lung cancer is the leading cause of cancer related deaths in Europe. Majority of the lung cancer patients in Europe were found to be suffering from Non-Small Cell Lung Cancer (NSCLC) in 2014, and the trend is anticipated to continue through 2020. Hence, with increasing prevalence of NSCLC among European citizens, demand for NSCLC treatment is forecast to grow at a robust pace over the next five years.

“Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the non- small cell lung cancer treatments market in the Europe during the period 2010 - 2020. In the study, the market has been categorized into four broader segments that include Chemotherapy, Surgery, Radiotherapy & Target Therapy.

The market dynamics section of the report elaborates the factors that are driving the market as well as the challenges inhibiting growth. The research study also includes insights of the key market trends, a detailed analysis of the changing competitive landscape, and revenue forecasts for each segment and sub-segment.

All this information is provided to assist the established market players and new entrants in taking their strategic decisions, thereby aiding them in strengthening their market position in a highly competitive non-small cell lung cancer treatments market in Europe.

“Europe Non-Small Cell Lung Cancer Treatments Market Opportunities, 2010 - 2020” report elaborates the following aspects of non-small cell lung cancer treatments market in Europe:

ü  Europe Non-Small Cell Lung Cancer Treatments Market Size, Share & Forecast

ü  Segmental Analysis – By Target Disease, By Type, By Region, By Company

ü  Policy & Regulatory Landscape

ü  Changing Market Trends & Emerging Opportunities

ü  Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

ü  To identify the on-going trends and anticipated growth in the next five years

ü  To gain competitive knowledge of leading market players

ü  To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer’s specific needs   

Key Questions This Study Will Answer

ü  What would be the segmental and regional growth trends in the Europe non-small cell lung cancer treatments market in the coming years?

ü  What are the most important growth drivers and opportunities in the market?

ü  Which therapy is preferred the most?

ü  What strategies should market competitors employ to gain share in mature segments of the Europe non-small cell lung cancer treatments market?

ü  What are the competitor profiles in this market and how do they compete for market share?

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviewswith NSCLC drug manufacturers, healthcare providers and industry experts.Secondary research included an exhaustive search of relevant publications likecompany annual reports, financial reports and proprietary databases.

Please Select Format

Single User License

$3000

Single User License Print

$3500

Enterprise License

$7000

For Queries Please Contact us

sales@pharmaion.com

+1 646 862 0089

10% Customization